Mean GTQ scores for trismus and non-trismus patients.
收藏NIAID Data Ecosystem2026-03-12 收录
数据链接：
官方服务：
资源简介：
Mean GTQ scores for trismus and non-trismus patients.
应用场景：
创建时间：
2020-12-17
相关数据集
Supplemental Table 1. Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck squamous cell carcinoma
Supplemental Table 1. Real-world time on treatment among patients with R/M HNSCC who initiated second-line systemic therapy on or before June 30, 2019
Figshare2021-05-28 更新50
Supplementary Table S8 from Epidermal growth factor receptor inhibition by cetuximab modulates hypoxia and interferon response genes in head and neck squamous cell carcinoma
Supplementary Table S8. Hypoxia-Immune classification of Schmitz et al., window-of-opportunity trial (GSE109756)
Figshare2023-05-04 更新20
Pembrolizumab and Cabozantinib in patients with Recurrent Metastatic Head and Neck Squamous Cell Carcinoma
We conducted a phase II multicenter single arm trial of pembrolizumab and cabozantininb in patients with Recurrent Metastatic Head and Neck Squamous Cell Carcinoma). We extracted DNA from 16 tumors an
NIAID Data Ecosystem10
Supporting the use of adjuvant radiotherapy in recurrent pleomorphic adenoma of the parotid
The use of adjuvant radiotherapy remains controversial in the treatment of recurrent pleomorphic adenomas. The aim of this study was to provide the highest level of evidence possible by performing a s
Taylor & Francis Group2023-04-19 更新30
Concurrent immunotherapy and radiation in cisplatin-ineligible patients with HNSCC: a systematic review & meta-analysis
Head and squamous cell carcinoma (HNSCC) in the locally advanced setting is challenging to treat and remains an area of significant morbidity and mortality. For patients who are cisplatin-ineligible a
NIAID Data Ecosystem10
